- Active Pharma Ingredients (API)
- Custom Pharma Services (CPS)
- Generics
- Generic Biopharmaceuticals
- New Chemical Entities & Differentiated Formulations
- Contact Us
CPS Mexico
Our API facility in Mexico gives us niche steroidal API capacities and has the world’s largest capacity for sodium naproxen
Our API facility in Mexico gives us niche steroidal API capacities and has the world’s largest capacity for sodium naproxen
Our Custom Pharmaceutical Services (CPS) business serves several ‘innovators’, both Big Pharma and emerging biotech, and a large number of emerging Pharma companies. Within a short span, we have become the largest CPS player from India and a partner-of-choice to innovators, offering top-end technical expertise, tailor-made pharma solutions and a track record of bringing innovations to the market quickly, efficiently and economically.
We offer both speed and flexibility. We have the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. Our end-to-end services and competitive pricing makes a compelling value proposition to our global ‘innovator’ customers.
We offer both speed and flexibility. We have the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. Our end-to-end services and competitive pricing makes a compelling value proposition to our global ‘innovator’ customers.
Niche technology-led acquisitions have made us a one-stop shop for many customers. Our acquisition of Roche's API manufacturing unit in Mexico added the capability to manufacture niche steroidal APIs. The acquisition of the Small Molecule business of Dow Pharma at its Mirfield and Cambridge sites in the UK has further strengthened our portfolio and service offerings for our customers. We now also offer a pool of chiral technologies, including biocatalysis.
We aim to be the preferred partner for innovator companies by providing a complete range of services that are necessary to take their innovations to the market with greater speed, efficiency and lower capital expenditures.
We aim to be the preferred partner for innovator companies by providing a complete range of services that are necessary to take their innovations to the market with greater speed, efficiency and lower capital expenditures.
CPS Mirfield
The chiral and biocatalysis technology at the Cambridge facility and the scale up capability in Mirfield adds significant value to the CPS business offerings.
The chiral and biocatalysis technology at the Cambridge facility and the scale up capability in Mirfield adds significant value to the CPS business offerings.
Designed by